Skip to content
lifestyle.floredechampagne.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Tarsus Pharmaceuticals, Inc
TP-03 (lotilaner ophthalmic solution) 0.25% Now Approved in China for the Treatment of Demodex Blepharitis, Triggering a $15M Milestone Payment to Tarsus
March 23, 2026
Tarsus to Participate in Upcoming Investor Conferences
February 26, 2026
Tarsus Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Business Achievements
February 23, 2026
Tarsus to Report Fourth Quarter and Full Year 2025 Financial Results on Monday, February 23, 2026
February 21, 2026
←
Previous Page
1
2